Article

Cancer clinical trials : identifying & testing approaches to impact evaluation

2021-01-01

Abstract excerpt

Most cancer research is performed with the aim of generating new knowledge that leads to benefits such as improved treatments, higher cure rates, and better cancer prevention. Evaluating these downstream effects of research, often referred to as research impact, is of increasing importance to all cancer research stakeholders. There is currently no consensus surrounding the optimal way to approach this evaluation....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e518f0d3-71b5-554f-9fd2-01ec68d7c163
DOI: 10.5525/gla.thesis.82407

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Cancer clinical trials : identifying & testing approaches to impact evaluationDOI 10.5525/gla.thesis.82407Read

An Evidenced-Based Prior for Estimating the Treatment Effect of Phase III Randomized Trials in OncologySemantic proximity Read

Lessons From ADAURA on Adjuvant Cancer Drug Trials: Evidence, Ethics, and Economics.Semantic proximity Read

Reporting of Health-Related Quality of Life Outcome Measures in Genotype based Targeted Therapies for Advanced CancersSemantic proximity Read

Success Rates and Timelines of African-Inclusive Phase III Trials: A Retrospective AnalysisSemantic proximity Read

Success Rates and Timelines of African-Inclusive Phase III Trials: A Retrospective AnalysisSemantic proximity Read

Does The Reformed Cancer Drug Fund Generate Evidence On Effectiveness? A Cross-sectional Analysis On Publicly Accessible DocumentationSemantic proximity Read

The European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS) applied to pivotal phase III randomized-controlled trials of tyrosine kinase inhibitors in first-line for advanced non-small cell lung cancer with activating epidermal growth factor receptor mutations.Semantic proximity Read

Summary measures in non-inferiority clinical trials with a time-to-event outcome: an empirical comparison of powerSemantic proximity Read

Randomized clinical trials with biomarkers: design issues.Semantic proximity Read

Statistical models to capture the association between progression-free and overall survival in oncology trialsSemantic proximity Read

Transfer of Statistical Innovations of the 1990s-2000s in Oncology to the Biomedical LiteratureSemantic proximity Read

Validate Real-World Data-based Endpoint Measures of Cancer Treatment OutcomesSemantic proximity Read